4.6 Review

FG syndrome, an X-linked multiple congenital anomaly syndrome: The clinical phenotype and an algorithm for diagnostic testing

Journal

GENETICS IN MEDICINE
Volume 11, Issue 11, Pages 769-775

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1097/GIM.0b013e3181bd3d90

Keywords

FG syndrome; Opitz-Kaveggia syndrome; MED12; p.R961W; X-linked mental retardation; multiple congenital anomalies; algorithm

Funding

  1. Action Medical Research
  2. NIHR
  3. South Carolina Department of Disabilities and Special Needs
  4. NIH [HD26202]
  5. Share's Childhood Disability Center
  6. Steven Spielberg Pediatric Research Center
  7. NIH/NICHD [HD22657]
  8. Medical Genetics NIH/NIGMS [5-T32-GM08243]
  9. US DHHS
  10. HRSA
  11. Division of Genetic Services [6 U22MC03959-04-03]

Ask authors/readers for more resources

FG syndrome is a rare X-linked multiple congenital anomaly-cognitive impairment disorder caused by the p.R961W mutation in the MED12 gene. We identified all known patients with this mutation to delineate their clinical phenotype and devise a clinical algorithm to facilitate molecular diagnosis. We ascertained 23 males with the p.R961W mutation in MED12 from 9 previously reported FG syndrome families and I new family. Six patients are reviewed in detail. These 23 patients were compared with 48 MED12 mutation-negative patients, who had the clinical diagnosis of FG syndrome. Traits that best discriminated between these two groups were chosen to develop an algorithm with high sensitivity and specificity for the p.R961W MED12 mutation. FG syndrome has a recognizable dysmorphic phenotype with a high incidence of congenital anomalies. A family history of X-linked mental retardation, deceased male infants, and/or multiple fetal losses was documented in all families. The algorithm identifies the p.R961W MED12 mutation-positive group with 100% sensitivity and 90% specificity. The clinical phenotype of FG syndrome defines a recognizable pattern of X-linked multiple congenital anomalies and cognitive impairment. This algorithm can assist the clinician in selecting the patients for testing who are most likely to have the recurrent p.R961W MED12 mutation. Genet Med 2009:11(11):769-775.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available